PrEMO

Study short name: PrEMO

Study full name:  An Open-label Study of Probiotic and Hen’s Egg or Cow’s Milk Oral Immunotherapy (Probiotic and Egg or Milk Oral Immunotherapy: PrEMO study).

Principle Investigator: Adriana Lozinsky

Administering Institute: Murdoch Children’s Research Institute

Major funding source: Prota Therapeutics

Study focus: Treatment

Study design: Intervention

Main study aim: To assess the rate of sustained unresponsiveness and desensitisation following 18 months of probiotic egg oral immunotherapy (OIT) or probiotic milk OIT.

Additional study information: This is a pilot study investigating whether probiotic given in combination with egg or milk OIT is effective at inducing sustained unresponsiveness in egg and/or milk allergic children.  

Study Population: The participants in this study are aged between 5 and 17 years old at time of enrolment. Participants are allergic to egg or milk, and may have additional food allergies.

Study status: Recruitment closed. Data collection ongoing, through mid-2021.

Australia New Zealand Clinical Trials Registry: https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12619000306112

Study contact: [email protected]

Last modified: May 29th 2020 | Date created: May 9th 2019